P2D Bioscience - Product Pipeline Review - 2014

Date: November 24, 2014
Pages: 34
Price:
US$ 1,500.00 US$ 1,350.00
Offer valid until December 31, 2014!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PA5FB80A2F2EN
Leaflet:

Download PDF Leaflet

P2D Bioscience - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘P2D Bioscience - Product Pipeline Review - 2014’, provides an overview of the P2D Bioscience’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of P2D Bioscience’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides brief overview of P2D Bioscience including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of P2D Bioscience’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the P2D Bioscience’s pipeline products
Reasons to buy
  • Evaluate P2D Bioscience’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of P2D Bioscience in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the P2D Bioscience’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of P2D Bioscience and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of P2D Bioscience
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of P2D Bioscience and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
P2D Bioscience Snapshot
P2D Bioscience Overview
Key Information
Key Facts
P2D Bioscience - Research and Development Overview
Key Therapeutic Areas
P2D Bioscience - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
P2D Bioscience - Pipeline Products Glance
P2D Bioscience - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
P2D Bioscience - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
P2D Bioscience - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
P2D Bioscience - Drug Profiles
betahistine hydrochloride
Product Description
Mechanism of Action
R&D Progress
0.02
Product Description
Mechanism of Action
R&D Progress
IDT
Product Description
Mechanism of Action
R&D Progress
PD-2005
Product Description
Mechanism of Action
R&D Progress
PD-2007
Product Description
Mechanism of Action
R&D Progress
PD-2015
Product Description
Mechanism of Action
R&D Progress
PD-2016
Product Description
Mechanism of Action
R&D Progress
PD-2024
Product Description
Mechanism of Action
R&D Progress
PD-3766
Product Description
Mechanism of Action
R&D Progress
PD-4048
Product Description
Mechanism of Action
R&D Progress
PD-4074
Product Description
Mechanism of Action
R&D Progress
Drug for Attention Deficit Hyperactivity Disorder
Product Description
Mechanism of Action
R&D Progress
P2D Bioscience - Pipeline Analysis
P2D Bioscience - Pipeline Products by Target
P2D Bioscience - Pipeline Products by Route of Administration
P2D Bioscience - Pipeline Products by Molecule Type
P2D Bioscience - Pipeline Products by Mechanism of Action
P2D Bioscience - Dormant Projects
P2D Bioscience - Locations And Subsidiaries
P2D Bioscience - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

P2D Bioscience, Key Information
P2D Bioscience, Key Facts
P2D Bioscience - Pipeline by Indication, 2014
P2D Bioscience - Pipeline by Stage of Development, 2014
P2D Bioscience - Monotherapy Products in Pipeline, 2014
P2D Bioscience - Phase I, 2014
P2D Bioscience - Preclinical, 2014
P2D Bioscience - Unknown, 2014
P2D Bioscience - Pipeline by Target, 2014
P2D Bioscience - Pipeline by Route of Administration, 2014
P2D Bioscience - Pipeline by Molecule Type, 2014
P2D Bioscience - Pipeline Products by Mechanism of Action, 2014
P2D Bioscience - Dormant Developmental Projects,2014

LIST OF FIGURES

P2D Bioscience - Pipeline by Top 10 Indication, 2014
P2D Bioscience - Pipeline by Stage of Development, 2014
P2D Bioscience - Monotherapy Products in Pipeline, 2014
P2D Bioscience - Pipeline by Top 10 Target, 2014
P2D Bioscience - Pipeline by Top 10 Molecule Type, 2014
P2D Bioscience - Pipeline Products by Top 10 Mechanism of Action, 2014

Ask Your Question

P2D Bioscience - Product Pipeline Review - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: